Several analysts have recently updated their ratings and price targets for Legend Biotech (NASDAQ: LEGN): 8/2/2023 – Legend Biotech is now covered by analysts at Citigroup Inc.. They set a “buy” rating on the stock. 7/21/2023 – Legend Biotech had its price target raised by analysts at Barclays PLC from $90.00 to $92.00. They now […]
Legend Biotech (NASDAQ:LEGN – Get Free Report) had its price target raised by equities researchers at HC Wainwright from $82.00 to $85.00 in a research report issued to clients and investors on Friday, FlyOnTheWall reports. HC Wainwright’s target price would suggest a potential upside of 11.83% from the stock’s current price. Several other brokerages have […]
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report)’s stock price hit a new 52-week high during trading on Friday after HC Wainwright raised their price target on the stock from $82.00 to $85.00. HC Wainwright currently has a buy rating on the stock. Legend Biotech traded as high as $77.32 and last traded at $76.31, […]
Moore Capital Management LP bought a new position in Legend Biotech Co. (NASDAQ:LEGN – Get Rating) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 10,000 shares of the company’s stock, valued at approximately $499,000. Other large investors also recently added to or reduced their […]
Legend Biotech Co. (NASDAQ:LEGN – Get Rating) – Analysts at HC Wainwright lifted their Q2 2023 earnings estimates for Legend Biotech in a research report issued to clients and investors on Tuesday, June 6th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.34) per share for the quarter, up from their […]